IPO
-
-
-
-
-
-
-
Ionis Reports Fourth Quarter and Full Year 2017 Financial Results
-
-
-
-
-
-
-
Akcea Therapeutics to Hold Fourth Quarter 2017 Financial Results Webcast
-
-
-
-
-
-
-
Akcea Initiates Phase 2 Study of AKCEA-ANGPTL3-LRx in Patients with Hypertriglyceridemia, Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease (NAFLD)
-
-
-
-
-
-
-
Akcea and Ionis Report Positive Phase 1/2a Data with AKCEA-APOCIII-LRx
-
-
-
-
-
-
-
Akcea (AKCA) and Ionis (IONS) Announce Submission of MAA for Volanesorsen
-
-
-
-
-
-
-
Ionis Reports Financial Results and Highlights for First Quarter 2017
-
-
-
95,865 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All